Cite
HARVARD Citation
Xu-Monette, Z. et al. (2019). Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies. Journal for immunotherapy of cancer. 7 (1), p. . [Online].